Hyperscale Data Issues Strategic Statement by Its Executive Chairman on Omnipresent Robotics and U.S. Based Robotics Infrastructure and Embodied AI Development
LAS VEGAS, April 20, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI“) data center company anchored... Read more.
Abacus Expands Incident Response Team in the UK
The continued expansion of the Abacus breach recovery team strengthens the firm’s global “follow-the-sun” coverage model. LONDON, April 20, 2026... Read more.
Atlas Cloud Makes Seedance 2.0 Available to Global Developers — Transparent Per-Second Pricing, No Waitlist
NEW YORK, April 20, 2026 /PRNewswire/ — Atlas Cloud has opened full API access to Seedance 2.0, ByteDance’s most advanced AI video generation model.... Read more.
DEKRA Continues its Growth Trajectory Amid Challenging Market Conditions
Results in anniversary year 2025 Revenue increases by 3.4% to 4.4 billion euros Continued strong demand for testing and certification services Independent expertise... Read more.
Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ
SHANGHAI, April 20, 2026 /PRNewswire/ — Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully... Read more.
Labbit Goes All-In on LIMS Platform, Retires Semaphore Solutions Brand
After a decade of implementing laboratory systems for regulated labs, company consolidates under the Labbit name to focus entirely on its modern LIMS platform VANCOUVER,... Read more.
Ontinue Opens New Headquarters in Zurich, Strengthening Commitment to European Growth and Innovation
New Office Reflects Continued Investment in Talent, Customers, and Security Excellence Across DACH and Beyond ZURICH, April 20, 2026 /PRNewswire/ — Ontinue,... Read more.
CAMSO Construction Enters Key European Markets with Strong On-Ground Readiness
PARIS, April 20, 2026 /PRNewswire/ — CAMSO Construction has announced its market readiness across key European markets – France, Italy, Spain, and Portugal,... Read more.
AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026
SHANGHAI, April 20, 2026 /PRNewswire/ — AlphaGen Therapeutics (AlphaGen), a biopharmaceutical company that focuses on developing next-generation targeted alpha... Read more.
AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026
SHANGHAI, April 20, 2026 /PRNewswire/ — AlphaGen Therapeutics (AlphaGen), a biopharmaceutical company that focuses on developing next-generation targeted alpha... Read more.